Siegfried Holding AG
SIX:SFZN

Watchlist Manager
Siegfried Holding AG Logo
Siegfried Holding AG
SIX:SFZN
Watchlist
Price: 1 114 CHF 0.91% Market Closed
Market Cap: 4.8B CHF
Have any thoughts about
Siegfried Holding AG?
Write Note

Siegfried Holding AG
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Siegfried Holding AG
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Siegfried Holding AG
SIX:SFZN
Accounts Payable
CHf91.1m
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Accounts Payable
CHf41.6m
CAGR 3-Years
24%
CAGR 5-Years
43%
CAGR 10-Years
17%
Lonza Group AG
SIX:LONN
Accounts Payable
CHf468m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tecan Group AG
SIX:TECN
Accounts Payable
CHf34.4m
CAGR 3-Years
42%
CAGR 5-Years
27%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Accounts Payable
€60.9m
CAGR 3-Years
29%
CAGR 5-Years
33%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Accounts Payable
CHf28m
CAGR 3-Years
-1%
CAGR 5-Years
134%
CAGR 10-Years
N/A
No Stocks Found

Siegfried Holding AG
Glance View

Market Cap
4.8B CHF
Industry
Life Sciences Tools & Services

Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. The company is headquartered in Zofingen, Aargau and currently employs 3,432 full-time employees. The firm produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The firm's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The firm operates production facilities in Switzerland, Germany, France, Malta, the United States and China.

SFZN Intrinsic Value
1 192.72 CHF
Undervaluation 7%
Intrinsic Value
Price

See Also

What is Siegfried Holding AG's Accounts Payable?
Accounts Payable
91.1m CHF

Based on the financial report for Jun 30, 2024, Siegfried Holding AG's Accounts Payable amounts to 91.1m CHF.

What is Siegfried Holding AG's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
9%

Over the last year, the Accounts Payable growth was 0%. The average annual Accounts Payable growth rates for Siegfried Holding AG have been -1% over the past three years , 9% over the past five years .

Back to Top